- Home
- FEBO vs ALBT Comparison
FEBO vs ALBT Comparison
Compare FEBO & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEBO
- ALBT
- Stock Information
- Founded
- FEBO 1993
- ALBT 2014
- Country
- FEBO Hong Kong
- ALBT United States
- Employees
- FEBO 280
- ALBT N/A
- Industry
- FEBO
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FEBO
- ALBT Health Care
- Exchange
- FEBO Nasdaq
- ALBT Nasdaq
- Market Cap
- FEBO 8.0M
- ALBT 7.4M
- IPO Year
- FEBO 2023
- ALBT N/A
- Fundamental
- Price
- FEBO $0.72
- ALBT $2.28
- Analyst Decision
- FEBO
- ALBT
- Analyst Count
- FEBO 0
- ALBT 0
- Target Price
- FEBO N/A
- ALBT N/A
- AVG Volume (30 Days)
- FEBO 21.0K
- ALBT 1.4M
- Earning Date
- FEBO 08-26-2025
- ALBT 08-26-2025
- Dividend Yield
- FEBO N/A
- ALBT N/A
- EPS Growth
- FEBO N/A
- ALBT N/A
- EPS
- FEBO N/A
- ALBT N/A
- Revenue
- FEBO $17,110,653.00
- ALBT $1,159,091.00
- Revenue This Year
- FEBO N/A
- ALBT N/A
- Revenue Next Year
- FEBO N/A
- ALBT N/A
- P/E Ratio
- FEBO N/A
- ALBT N/A
- Revenue Growth
- FEBO 11.58
- ALBT N/A
- 52 Week Low
- FEBO $0.66
- ALBT $1.87
- 52 Week High
- FEBO $8.50
- ALBT $11.66
- Technical
- Relative Strength Index (RSI)
- FEBO 30.30
- ALBT 46.85
- Support Level
- FEBO $0.70
- ALBT $2.17
- Resistance Level
- FEBO $0.78
- ALBT $2.27
- Average True Range (ATR)
- FEBO 0.08
- ALBT 0.20
- MACD
- FEBO -0.01
- ALBT 0.02
- Stochastic Oscillator
- FEBO 14.40
- ALBT 53.25
About FEBO Fenbo Holdings Limited
Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances, principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.